LYRA stock

Lyra Therapeutics Inc (LYRA) financials · rev $398.0K

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Lyra Therapeutics Inc (LYRA) rev $398.0K.

Cached annual income statement
LineFY2025FY2024
Revenue$398.0K$1.53M
Operating Income-$31.0M-$96.3M
Net Income-$28.9M-$93.4M
EPS (Diluted)-$18.62-$1.43
Cached annual balance sheet
LineFY2025FY2024
Total Assets$36.1M$66.3M
Current Assets$16.3M$43.0M
Cash & Equivalents$15.9M$40.6M
PP&E$1.05M$1.40M
Total Liabilities$46.8M$54.8M
Current Liabilities$9.52M$12.6M
Shareholders' Equity-$10.7M$11.6M
Retained Earnings-$433.7M-$404.8M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$28.9M-$70.0M
CapEx$116.0K$2.34M
Investing Cash Flow-$98.0K$80.3M
Financing Cash Flow$4.27M$8.53M
Net Change in Cash-$24.7M$18.8M
Free Cash Flow-$29.0M-$72.3M
These statements as JSON? API free 100/day

FAQ

What is LYRA P/E and revenue?

Lyra Therapeutics Inc (LYRA) rev $398.0K.

What is LYRA revenue?

Lyra Therapeutics Inc last cached revenue is $398.0K (FY2025).

Is LYRA profitable?

Lyra Therapeutics Inc last cached net income is -$28.9M (FY2025).

What are LYRA total assets?

Lyra Therapeutics Inc last cached total assets are $36.1M (FY2025).

What is LYRA free cash flow?

Lyra Therapeutics Inc last cached free cash flow is -$29.0M (FY2025).

Not investment advice. Cached statements, not a live tape.